Class IIITerminatedD-0752-2022
Drug recall · April 13, 2022
Methylprednisolone Tablets recall
Why: Subpotent
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Methylprednisolone Tablets, USP 4mg, 100-count bottle, Rx Only, Manufactured by: Jubliant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-001-06
- Lots / codes
Lot # 21 P0322, Exp. 01/2023
- Quantity
- 19,222 Bottles (100-count)
- Company
- Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD
- Distribution
- Nationwide in the USA and Puerto Rico
- Initiated
- April 1, 2022 · Voluntary: Firm initiated
- Classified
- April 6, 2022
- Reported
- April 13, 2022
- Ended
- April 3, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Methylprednisolone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.